An attractive drugtarget is the human transmembrane protease serine 2 (TMPRSS2) becauseof its vital role in the viral infection mechanism of SARS-CoV-2 byactivation of the virus spike protein (S protein). Here, TMPRSS2 is linked to viral infectious disease.